Through the development of more sophisticated systems, the time currently spent on manual sample preparation and detection could be significantly reduced," explains Mr. Shankar. "A major trend in instrumentation systems is an increase in the number of manufacturers that are focusing on low-throughput isolation instrumentation."
Low-throughput products are ideal for clinical laboratories where space and time are limited, but quality is essential. In Europe, there is a move towards the smaller and medium throughput instruments. This is due to more European countries operating smaller and medium-sized laboratories, which do not process as large a number of samples as the United States.
The demand for nucleic acid-based amplification kits has boomed and is anticipated to continue over the next decade. This is mainly due to the completion of the human genome project and growing interest in molecular diagnostics. Fuelled by the rich rewards of possible patents, there has been a rush to analyse genes and their functions.
Seems osmetech have adopted the perfect strategy, to best enhance future revenues.
Osmetech stock quotes
Osmetech stock charts
Follow this thread
